LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

Search

ICU Medical Inc

Geschlossen

BrancheGesundheitswesen

138.05 -0.19

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

136.94

Max

140.03

Schlüsselkennzahlen

By Trading Economics

Einkommen

-39M

-3.4M

Verkäufe

-12M

537M

Gewinnspanne

-0.632

Angestellte

15,000

EBITDA

-93M

14M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+23.61% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

404M

3.4B

Vorheriger Eröffnungskurs

138.24

Vorheriger Schlusskurs

138.05

Nachrichtenstimmung

By Acuity

50%

50%

171 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

ICU Medical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Nov. 2025, 21:34 UTC

Ergebnisse

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13. Nov. 2025, 23:45 UTC

Market Talk

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13. Nov. 2025, 23:42 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13. Nov. 2025, 23:41 UTC

Market Talk

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13. Nov. 2025, 23:24 UTC

Ergebnisse

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13. Nov. 2025, 23:24 UTC

Ergebnisse

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13. Nov. 2025, 23:23 UTC

Ergebnisse

JBS NV 3Q EPS 52c >JBS

13. Nov. 2025, 23:23 UTC

Ergebnisse

JBS NV 3Q Sales $22.6B >JBS

13. Nov. 2025, 23:04 UTC

Market Talk

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13. Nov. 2025, 22:02 UTC

Ergebnisse

Nu Holdings 3Q Net $783M >NU

13. Nov. 2025, 22:01 UTC

Ergebnisse

Nu Holdings 3Q Rev $4.2B >NU

13. Nov. 2025, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13. Nov. 2025, 21:50 UTC

Ergebnisse

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13. Nov. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13. Nov. 2025, 21:41 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13. Nov. 2025, 21:33 UTC

Market Talk

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13. Nov. 2025, 21:33 UTC

Ergebnisse

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13. Nov. 2025, 21:31 UTC

Ergebnisse

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13. Nov. 2025, 21:25 UTC

Ergebnisse

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13. Nov. 2025, 21:25 UTC

Ergebnisse

Figure Tech Solutions 3Q EPS 34c >FIGR

13. Nov. 2025, 21:23 UTC

Ergebnisse

Intchains Group 3Q Rev $1.3M >ICG

13. Nov. 2025, 21:03 UTC

Ergebnisse

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13. Nov. 2025, 21:02 UTC

Ergebnisse

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13. Nov. 2025, 21:01 UTC

Ergebnisse

Applied Materials 4Q Rev $6.8B >AMAT

13. Nov. 2025, 21:01 UTC

Ergebnisse

Applied Materials 4Q Gross Margin 48.0% >AMAT

Peer-Vergleich

Kursveränderung

ICU Medical Inc Prognose

Kursziel

By TipRanks

23.61% Vorteil

12-Monats-Prognose

Durchschnitt 172 USD  23.61%

Hoch 172 USD

Tief 172 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ICU Medical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

137.16 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

171 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat